Content provided in partnership with
Technology Industry
Industry: Email Alert RSS FeedStemCo Biomedical Inc
BT Catalyst, Sept, 2002
StemCo Biomedical Inc. of Durham has received a $109,000 Phase I Small Business Innovation Research grant from the National Institutes of Health of Bethesda, Md., to support its project on the "Enumeration and Isolation of Human Hematopoetic Stem Cells." The project will use the company's proprietary Aldefluor reagent system to identify cells that have a high level of expression of the intracellular enzyme aldehyde dehydrogenase (ALDHbright).
- Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »
ALDHbright cells can be isolated for use in transplantation therapy in the treatment of cancer, autoimmune and genetic diseases.
COPYRIGHT 2002 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning
Find Research Guides for:
Find Featured Titles for: Home & Garden
Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »